摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-hydroxysuccinimidyl 2-[(triphenylmethylthio)methylcarbonylamino]ethanoate | 91425-33-1

中文名称
——
中文别名
——
英文名称
N-hydroxysuccinimidyl 2-[(triphenylmethylthio)methylcarbonylamino]ethanoate
英文别名
——
N-hydroxysuccinimidyl 2-[(triphenylmethylthio)methylcarbonylamino]ethanoate化学式
CAS
91425-33-1
化学式
C27H24N2O5S
mdl
——
分子量
488.564
InChiKey
FXKKJRWYAMNSSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.44
  • 重原子数:
    35.0
  • 可旋转键数:
    9.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    92.78
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

SDS

SDS:c9ad0793eb620dc58b3c1a22662fd15a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-hydroxysuccinimidyl 2-[(triphenylmethylthio)methylcarbonylamino]ethanoate 4-二甲氨基吡啶一水合肼三乙胺 作用下, 以 四氢呋喃乙醇1,2-二氯乙烷乙腈 为溶剂, 反应 10.0h, 生成 Ethyl 3-[[4-hydroxy-3-[[2-[(2-tritylsulfanylacetyl)amino]acetyl]amino]phenyl]carbamothioylamino]propanoate
    参考文献:
    名称:
    基于 ON2S 配体的原始双功能螯合剂的便捷合成及其与氧铼(V)核的配位化学
    摘要:
    用于氧铼核心的半刚性、四齿双功能螯合剂 (BFC) 已通过五个步骤合成,总产率为 46%。芳香胺可通过异硫氰酸酯功能与肽结合。该 BFC 是第一个包含酰胺基和硫醇官能团的胺官能化四齿配体。Monooxorhenium 配合物很容易从双功能螯合剂和 β-丙氨酸-共轭系统制备。这些复合物以良好的收率获得并且被充分表征。此外,发现它们对配体交换反应稳定。 (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)
    DOI:
    10.1002/ejoc.200500810
  • 作为产物:
    参考文献:
    名称:
    新的半刚性配体家族的设计和合成:用于制备99mTc放射性药物的通用化合物。
    摘要:
    已开发出设计用于协调99 99m的一系列新型半刚性四齿配体(具有硫,酰胺基或氨基供体基团)的合成途径。制备了-99m配合物,并比较了它们在血清中的稳定性以及通过半胱氨酸交换反应进行的复分解反应的稳定性。两种(99m)Tc配合物及其their类似物的HPLC比较导致我们放射性配合物性质的第一个证明。
    DOI:
    10.1039/b313996d
点击查看最新优质反应信息

文献信息

  • Rhenium(<scp>v</scp>) oxocomplexes with novel pyrazolyl-based N<sub>4</sub>- and N<sub>3</sub>S-donor chelators
    作者:Carolina Moura、Rute F. Vítor、Leonor Maria、António Paulo、Isabel C. Santos、Isabel Santos
    DOI:10.1039/b611034g
    日期:——
    The novel pyrazolyl-based ligands 3,5-Me2pz(CH2)2NH(CH2)2NH(CH2)2NH2 (1) and pz*(CH2)2NH-Gly-CH2STrit (pz* = pz (8), 3,5-Me2pz (9), 4-(EtOOC)CH2-3,5-Me2pz (10)) were synthesized, and their suitability to stabilize Re(V) oxocomplexes was evaluated using different starting materials, namely (NBu4)[ReOCl4], [ReOCl3(PPh3)2] and trans-[ReO2(py)4]Cl. Compound 1 reacts with trans-[ReO2(py)4]Cl yielding the cationic compound [ReO(OMe)3,5-Me2pz(CH2)2N(CH2)2NH(CH2)2NH2}](BPh4) (11) in a low isolated yield. In contrast, the neutral complexes [ReOpz*(CH2)2NH-Gly-CH2S}] (pz* = pz (12), 3,5-Me2pz (13), 4-(EtOOCCH2)-3,5-Me2pz (14)) were synthesized almost quantitatively by reacting [ReOCl3(PPh3)2] or (NBu4)[ReOCl4] with the trityl-protected chelators 8–10. The X-ray diffraction analysis of 11 and 13 confirmed the tetradentate coordination mode of the respective ancillary ligands. In 11 the monoanionic chelator coordinates to the metal through four nitrogen atoms, while in 13 the chelator is trianionic, coordinating to the metal through three nitrogens and one sulfur atom. Solution NMR studies of 12–14, including two-dimensional NMR techniques (1H COSY and 1H/13C HSQC), confirmed that the N3S coordination mode of the chelators is retained in solution. Unlike 11, complexes 12–14 may be considered relevant in the development of radiopharmaceuticals, as further corroborated by the synthesis of the congener [99mTcOpz(CH2)2-NH-Gly-CH2S}] (12a). This radioactive compound was obtained from 99mTcO4− in aqueous medium, in almost quantitative yield and with high specific activity and radiochemical purity.
    合成了新型的以吡唑基为基础的配体3,5-Me2pz(CH2)2NH( )2NH( )2NH2 (1)和pz*( )2NH-Gly- STrit(pz* = pz (8),3,5-Me2pz (9),4-(EtOOC) -3,5-Me2pz (10)),并评估了它们稳定Re(V)氧化络合物的适用性,使用的起始材料分别为(NBu4)[ReOCl4]、[ReOCl3(PPh3)2] 和 trans-[ReO2(py)4]Cl。化合物1与trans-[ReO2(py)4]Cl反应,生成阳离子化合物[ReO(OMe)3,5-Me2pz( )2N( )2NH( )2NH2}](BPh4) (11),其孤立产率较低。相比之下,几乎定量合成了中性复合物[ReOpz*( )2NH-Gly- S}] (pz* = pz (12),3,5-Me2pz (13),4-(EtOOC )-3,5-Me2pz (14)),通过将[ReOCl3(PPh3)2]或(NBu4)[ReOCl4]与三苯基保护的螯合剂8–10反应。对11和13的X射线衍射分析确认了各自辅助配体的四齿配位模式。在11中,单阴离子螯合剂通过四个氮原子与属配位,而在13中,螯合剂是三阴离子,通过三个氮和一个原子与属配位。对12–14的溶液NMR研究,包括二维NMR技术(1H COSY和1H/13C HSQC),确认了螯合剂的N3S配位模式在溶液中的保留。与11不同,复合物12–14被认为在放射药物开发中具有相关性,进一步通过合成同类物[99mTcOpz( )2-NH-Gly- S}] (12a)得到了印证。该放射性化合物在相中从99mTcO4−获得,几乎定量收率,并具有高特异活性和放射化学纯度。
  • Synthesis, metal complexation and biological evaluation of a novel semi-rigid bifunctional chelating agent for 99mTc labelling
    作者:Julien Le Gal、Sandra Michaud、Marie Gressier、Yvon Coulais、Eric Benoist
    DOI:10.1016/j.bmc.2005.12.005
    日期:2006.5
    A novel bifunctional chelating agent bearing an aromatic ring has been synthesised and characterised. This ligand formed well-defined oxorhenium complexes. The analogous 99mTcO-complex was obtained in an excellent yield with high radiochemical purity (>95%). The biodistribution of the 99mTc-complex after intravenous injection studied in normal rats showed that the activity was excreted mainly via renal-urinary
    合成并表征了新型的带有芳香环的双官能螯合剂。该配体形成明确的氧络合物。以优异的收率获得了类似的99mTcO复合物,并具有较高的放射化学纯度(> 95%)。正常大鼠静脉注射后99mTc复合物的生物分布研究表明,该活性主要通过肾泌尿途径排泄,表明其可用于标记99mTc肽。
  • Qi, Chuan-Min; Feng, Shu-Juan; Zhang, Hua-Bei, Medicinal Chemistry Research, 2003, vol. 12, # 9, p. 471 - 480
    作者:Qi, Chuan-Min、Feng, Shu-Juan、Zhang, Hua-Bei、Huang, Hai-Bo、Li, Bo
    DOI:——
    日期:——
  • SYNTHESIS BIODISTRIBUTION AND QSAR STUDIES OF FIVE Tc-99M LABELED NOVEL N3S PSEUDO-PEPTIDE COMPLEXES
    作者:Hua-bei Zhang、Hai-hong Ye、Ya-ling Zhang、Xuefang Zheng、Jian-sheng Han、Hua Li、Chun-ping Liu
    DOI:10.1007/s00044-004-0124-5
    日期:2005.1
    Five novel N3S pseudo-peptide chelators derived from mercaptoacetic acid have been synthesized and characterized based on the spectroscopic data. All the chelators were labeled with Technicium-99m to evaluate their biological activities. Investigations of their biodistribution in mice showed all five pseudo-peptide chelators (MGQ, MGGQ, MAGQ, MVGQ, MFGQ) are rapidly cleared from blood, mainly through renal clearance. Tc-99m-MGGQ and Tc-99m-MVGQ had high kidney uptake, quick blood clearance and high activity ratios of kidney to blood, thus showing potential application as renal imaging agents. Quantitative structure-activity relationship studies were performed. Linear regression analysis between the logarithm of renal uptake value (log%ID) and the parameters obtained from the ZINDO/1 method elicited several equations that possessed certain predictive qualities, and may play a direct part in drug design and synthesis.
查看更多

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 重氮四苯基乙烷 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲醇,2-氨基-5-氯-a-乙烯基-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲酸,3-[[2-[[(1,1-二甲基乙氧基)羰基]氨基]-3-[(三苯代甲基)硫代]丙基]氨基]-,(R)- 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 苄基 2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷 芴甲氧羰基-4-叔丁酯-天冬酰胺-S-三氯苯甲基-L-半胱氨酸 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磺基琥珀酰亚胺基-4-[2-(4,4-二甲氧基三苯甲基)]丁酸酯 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-6-O-三苯甲基-beta-D-吡喃半乳糖苷 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷